U.S. Physical Therapy Beheer
Beheer criteriumcontroles 3/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Chris Reading
Algemeen directeur
US$3.4m
Totale compensatie
Percentage CEO-salaris | 28.4% |
Dienstverband CEO | 20yrs |
Eigendom CEO | 0.6% |
Management gemiddelde ambtstermijn | 6.7yrs |
Gemiddelde ambtstermijn bestuur | 17.2yrs |
Recente managementupdates
Recent updates
U.S. Physical Therapy (NYSE:USPH) Might Be Having Difficulty Using Its Capital Effectively
Aug 07U.S. Physical Therapy (NYSE:USPH) Has A Rock Solid Balance Sheet
Jul 17U.S. Physical Therapy, Inc.'s (NYSE:USPH) Business Is Trailing The Industry But Its Shares Aren't
Jun 04There May Be Reason For Hope In U.S. Physical Therapy's (NYSE:USPH) Disappointing Earnings
May 21U.S. Physical Therapy (NYSE:USPH) Is Due To Pay A Dividend Of $0.44
May 11Returns On Capital Signal Tricky Times Ahead For U.S. Physical Therapy (NYSE:USPH)
May 05A Look At The Fair Value Of U.S. Physical Therapy, Inc. (NYSE:USPH)
Apr 21Is Now The Time To Look At Buying U.S. Physical Therapy, Inc. (NYSE:USPH)?
Apr 07U.S. Physical Therapy, Inc.'s (NYSE:USPH) Shareholders Might Be Looking For Exit
Mar 04The Returns On Capital At U.S. Physical Therapy (NYSE:USPH) Don't Inspire Confidence
Dec 23Why U.S. Physical Therapy, Inc. (NYSE:USPH) Could Be Worth Watching
Dec 07U.S. Physical Therapy: Positioned For Market Dominance Amidst Attractive Valuations
Oct 13Is U.S. Physical Therapy (NYSE:USPH) A Risky Investment?
Oct 13U.S. Physical Therapy (NYSE:USPH) Could Be Struggling To Allocate Capital
Sep 05Should You Think About Buying U.S. Physical Therapy, Inc. (NYSE:USPH) Now?
Aug 15Are U.S. Physical Therapy, Inc. (NYSE:USPH) Investors Paying Above The Intrinsic Value?
Aug 01U.S. Physical Therapy: Bolt-On Strategy Scaling Earnings Power (Rating Upgrade)
Jul 19At US$114, Is U.S. Physical Therapy, Inc. (NYSE:USPH) Worth Looking At Closely?
May 07U.S. Physical Therapy, Inc.'s (NYSE:USPH) Intrinsic Value Is Potentially 25% Below Its Share Price
Apr 16U.S. Physical Therapy (NYSE:USPH) Has A Pretty Healthy Balance Sheet
Apr 01Some Investors May Be Worried About U.S. Physical Therapy's (NYSE:USPH) Returns On Capital
Mar 04U.S. Physical Therapy beats Q4 top and bottom line estimates; initiates FY23 outlook
Feb 23U.S. Physical Therapy: Needs To Illustrate Economic Reality Over Accounting Profit
Feb 12Is Now An Opportune Moment To Examine U.S. Physical Therapy, Inc. (NYSE:USPH)?
Jan 24We Think U.S. Physical Therapy (NYSE:USPH) Can Stay On Top Of Its Debt
Dec 20Here's Why We Think U.S. Physical Therapy (NYSE:USPH) Is Well Worth Watching
Dec 05U.S. Physical Therapy: Not The Most Comfortable Prospect
Nov 09U.S. Physical Therapy acquires physical therapy practice for $19.3M
Nov 01U.S. Physical Therapy says Hurricane Ian affected about 50 clinics, ~$395K in lost sales
Oct 17Analyse CEO-vergoeding
Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
---|---|---|---|
Sep 30 2024 | n/a | n/a | US$14m |
Jun 30 2024 | n/a | n/a | US$16m |
Mar 31 2024 | n/a | n/a | US$18m |
Dec 31 2023 | US$3m | US$959k | US$18m |
Sep 30 2023 | n/a | n/a | US$24m |
Jun 30 2023 | n/a | n/a | US$26m |
Mar 31 2023 | n/a | n/a | US$28m |
Dec 31 2022 | US$2m | US$926k | US$29m |
Sep 30 2022 | n/a | n/a | US$39m |
Jun 30 2022 | n/a | n/a | US$38m |
Mar 31 2022 | n/a | n/a | US$37m |
Dec 31 2021 | US$4m | US$896k | US$31m |
Sep 30 2021 | n/a | n/a | US$31m |
Jun 30 2021 | n/a | n/a | US$30m |
Mar 31 2021 | n/a | n/a | US$32m |
Dec 31 2020 | US$3m | US$676k | US$32m |
Sep 30 2020 | n/a | n/a | US$30m |
Jun 30 2020 | n/a | n/a | US$31m |
Mar 31 2020 | n/a | n/a | US$29m |
Dec 31 2019 | US$3m | US$769k | US$31m |
Sep 30 2019 | n/a | n/a | US$30m |
Jun 30 2019 | n/a | n/a | US$23m |
Mar 31 2019 | n/a | n/a | US$18m |
Dec 31 2018 | US$3m | US$739k | US$17m |
Sep 30 2018 | n/a | n/a | US$18m |
Jun 30 2018 | n/a | n/a | US$22m |
Mar 31 2018 | n/a | n/a | US$21m |
Dec 31 2017 | US$2m | US$720k | US$22m |
Compensatie versus markt: De totale vergoeding ($USD 3.37M ) Chris } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 5.54M ).
Compensatie versus inkomsten: De beloning van Chris is het afgelopen jaar met meer dan 20% gestegen, terwijl de winst van het bedrijf met meer dan 20% is gedaald.
CEO
Chris Reading (60 yo)
20yrs
Tenure
US$3,372,377
Compensatie
Mr. Christopher J. Reading, also known as Chris, has been the Chief Executive Officer of US Physical Therapy Inc. since November 1, 2004 and serves as its Chairman since May 21, 2024 and served as its Pres...
Leiderschapsteam
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Chairman & CEO | 20yrs | US$3.37m | 0.64% $ 9.3m | |
President & COO | 3.3yrs | US$1.79m | 0.11% $ 1.6m | |
Chief Financial Officer | 4yrs | US$1.69m | 0.14% $ 2.0m | |
Executive VP | 13.8yrs | US$1.50m | 0.086% $ 1.3m | |
Chief Operating Officer - West | 6.7yrs | US$1.91m | 0.14% $ 2.1m | |
Senior Vice President of Finance & Accounting | 2.6yrs | geen gegevens | geen gegevens | |
Senior Vice President of Information Systems | no data | geen gegevens | geen gegevens | |
Senior VP & Chief Compliance Officer | no data | geen gegevens | geen gegevens | |
Vice President of Human Resources | no data | geen gegevens | geen gegevens | |
VP & Corporate Controller | 18yrs | geen gegevens | geen gegevens |
6.7yrs
Gemiddelde duur
60yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van USPH is doorgewinterd en ervaren (gemiddelde ambtstermijn van 6.7 jaar).
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Chairman & CEO | 20yrs | US$3.37m | 0.64% $ 9.3m | |
Independent Director | 1.5yrs | US$215.92k | 0.015% $ 221.8k | |
Independent Director | 19.8yrs | US$269.29k | 0.056% $ 817.9k | |
Lead Independent Director | 19.3yrs | US$264.29k | 0.12% $ 1.8m | |
Independent Director | 6.5yrs | US$256.54k | 0.13% $ 1.8m | |
Independent Director | 17.2yrs | US$236.54k | 0.13% $ 1.8m | |
Independent Director | 2.8yrs | US$239.04k | 0.037% $ 546.0k |
17.2yrs
Gemiddelde duur
67yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van USPH zijn ervaren en ervaren (gemiddelde ambtstermijn van 17.2 jaar).